Cardio Diagnostics Net Income Per Share Over Time
| CDIO Stock | USD 1.29 0.03 2.27% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cardio Diagnostics Performance and Cardio Diagnostics Correlation. Will Biotechnology sector continue expanding? Could Cardio diversify its offerings? Factors like these will boost the valuation of Cardio Diagnostics. Projected growth potential of Cardio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cardio Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (11.91) | Revenue Per Share | Quarterly Revenue Growth (0.57) | Return On Assets | Return On Equity |
Cardio Diagnostics's market price often diverges from its book value, the accounting figure shown on Cardio's balance sheet. Smart investors calculate Cardio Diagnostics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Cardio Diagnostics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cardio Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardio Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Per Share Analysis
Compare Cardio Diagnostics and related stocks such as Addex Therapeutics, Brainstorm Cell Ther, and Neurosense Therapeutics Net Income Per Share Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADXN | (4.0951) | (4.1907) | (3.4149) | (1.5952) | (0.1778) | (0.3874) | (0.276) | (0.2535) | (0.0706) | (0.56) | (0.4819) | (0.4518) | (0.4604) | (0.1421) | 0.0719 | 0.0647 | 0.068 |
| BCLI | (0.1424) | (0.4893) | (374) | (0.4562) | (8.3059) | (6.8765) | (4.0002) | (3.9164) | (10.0508) | (13.6384) | (14.0915) | (10.0872) | (9.9292) | (4.4782) | 2.189 | 1.97 | 2.07 |
| NRSN | (0.225) | (0.225) | (0.225) | (0.225) | (0.225) | (0.225) | (0.225) | (0.225) | (0.225) | (0.225) | (0.5124) | (0.3722) | (1.0726) | (0.741) | (0.5489) | (0.63) | (0.66) |
| MTNB | (0.5803) | (0.5803) | (0.5803) | (5.8018) | (15.9322) | (8.8726) | (6.5899) | (8.5584) | (7.1777) | (5.9825) | (5.7002) | (5.5389) | (4.8422) | (5.2797) | (4.9839) | (4.49) | (4.71) |
| CELZ | 57.1667 | (1 K) | (1.1 K) | (1.1 K) | (1.2 K) | (1.3 K) | (5.5 K) | (17.4 K) | (11.4 K) | (4.1 K) | (627) | 73.7482 | (9.2792) | (3.7557) | (3.7108) | (4.27) | (4.48) |
| ADIL | (4.2765) | (4.2765) | (4.2765) | (4.2765) | (4.2765) | (4.2765) | (2.1985) | (5.2031) | (61.0975) | (21.8002) | (21.7853) | (26.1225) | (11.9767) | (4.9148) | (0.71) | (0.64) | (0.67) |
| TCRT | (48.5509) | (145) | (184) | (99.6712) | (47.1386) | (144) | (190) | (59.5046) | (55.5197) | (105) | (57.2248) | (55.0966) | (26.065) | (21.969) | (2.9221) | (2.63) | (2.76) |
| BCDA | 22.0021 | 906 | 28.6089 | 1.7822 | 20.5011 | 27.8595 | (166) | (43.5418) | (49.2017) | (39.0896) | (22.242) | (11.1888) | (10.0821) | (8.1948) | (2.8958) | (2.61) | (2.74) |
| IBO | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0491) | (0.0442) | (0.0464) |
Cardio Diagnostics and related stocks such as Addex Therapeutics, Brainstorm Cell Ther, and Neurosense Therapeutics Net Income Per Share description
My Equities
My Current Equities and Potential Positions
| Cardio Diagnostics Holdings | CDIO |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 311 West Superior |
| Exchange | NASDAQ Exchange |
USD 1.29
Check out Cardio Diagnostics Performance and Cardio Diagnostics Correlation. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Cardio Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.